<DOC>
	<DOCNO>NCT02341248</DOCNO>
	<brief_summary>Exclusive Enteral Nutrition ( EEN ) liquid diet give child active Crohn 's Disease ( CD ) . EEN previously show induce change major bacterial metabolite dominant bacterial specie profound child clinically improve . This study aim determine whether possible maintain bacterial change prolong supplementary enteral nutrition ( SEN ) return normal diet reduce risk subsequent relapse child CD . New technology allow measurement broad range bacteria metabolite , test clinical response EEN change gut inflammation associate bacterial composition chemical products; maintenance change use SEN reduces risk relapse 12 month period . The study aim recruit potential Crohn 's disease child come tertiary paediatric centre colonoscopy . Once consent , initial blood , urine faecal sample request along 8 mucosal biopsy routine endoscopy session . If diagnosed CD , clinician prescribes treatment EEN , additional blood sample request end EEN , 5 faecal urine sample spread 12 months; well dietary information . Samples collect 42 child CD 42 age- sex-matched healthy volunteer . Initial sample take child diagnose CD compare CD sample look potential metabolic disease marker . Characterisation faecal bacteria metabolite faeces urine; well measurement blood inflammatory biomarkers perform .</brief_summary>
	<brief_title>Bacteria &amp; Inflammation Gut ( BIG ) Study</brief_title>
	<detailed_description>The null hypothesis clinical response exclusive enteral nutrition ( EEN ) reduction colonic inflammatory marker associate characteristic bacterial taxonomy ( composition ) metabolites ( functionality ) ; maintenance bacterial change supplementary enteral nutrition ( SEN ) , return habitual diet , reduce risk disease relapse . The study design build previous work look difference gut bacteria ( faecal mucosal ) bacterial metabolic activity different stage disease activity . Changes bacterial composition disease group examined; Crohn 's disease child different treatments; different site gut . Crohn 's disease biomarkers faeces urine also assess analyse bacterial metabolite . Up total 42 child Crohn 's Disease recruit . 42 healthy child also recruit provide faecal urine sample , show normal variety gut bacteria metabolites healthy child comparison . Children underwent colonoscopy Crohn 's disease use comparison group try identify Crohn 's disease bacterial signature faeces urine , non-Crohn 's disease control group comparison mucosal biopsy . Recruitment Three group child participate study . A . Children undergo endoscopic investigation ( colonoscopy ) colonic inflammation include Crohn 's disease [ child find Crohn 's disease participate follow aspect ( treatment EEN ) study ] . B . Previously diagnose patient Crohn 's disease due start 8 week standard course treatment EEN due disease flare . C. Healthy child unrelated Crohn 's disease patient use control group . Groups A B : initial blood , urine , faecal sample follow 5 faecal urine sample 12 month ; dietary information . [ Group A also 8 mucosal biopsy take routine endoscopy ] . During treatment EEN ( clinical decision ) , additional blood sample request routine blood sample start end treatment . Group C : 1 urine faecal sample request . All group height , weight grip strength measure baseline . Participant receive EEN repeat 60 day start treatment 60 day end treatment . Detailed Methods Preliminary health check mean short health questionnaire - basic health information , age , medication . Mucosal sample : newly diagnose patient colonoscopy diagnostic purpose , additional 6 mucosal biopsy sample ; 2 terminal ileum possible , 2 proximal colon 2 distal colon take ( 14-16 collect normal colonoscopy ) . An additional 2 biopsy sample also collect duodenum upper endoscopy . Dietary information : habitual dietary intake eat pattern assess use validate Food Frequency Questionnaire ( FFQ ) ; 5 step multiple pas 24 hour dietary recall questionnaire data actual diet time faecal urine sampling . EEN compliance ( group A &amp; B ) : completion short EEN compliance questionnaire 28 day 56 day time point . Medication Disease History : information disease activity , medication medical history collect medical note . Lab Assays Bacterial diversity : The gut bacterial diversity composition stool sample measure use molecular technique quantitative polymerase chain reaction ( PCR ) bacterial ribosomal DNA next generation sequencing ( metagenomics ) . These technique also use look composition bacteria associate mucosal tissue biopsy . Changes overall gut bacteria composition use standard numerical index measure across 6 faecal sample collect 12 month period , well group . Bacterial metabolism : A large number different product bacterial metabolism , short chain fatty acid , sulphide , ammonia measure use range technique include gas chromatography gas chromatography mass spectrometry ( GCMS ) ( metabolomics ) . Faecal pH , marker bacterial fermentation , also measure . Disease marker : Other disease marker metabolites faecal calprotectin , measure faecal sample .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Group A : child suspect Crohn 's Disease schedule colonoscopy Group B : child exist Crohn 's Disease undergo treatment EEN Group C : healthy volunteer age 17 year willing provide one urine stool sample child take antibiotic previous 4 week child find Crohn 's Disease colonoscopy require take part study</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Enteral Nutrition</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Microbiota</keyword>
	<keyword>Metabolomics</keyword>
</DOC>